Label: OREGANO ESSENCE- origanum vulgare leaf extract liquid

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: unapproved drug other

DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

Drug Label Information

Updated November 13, 2020

If you are a consumer or patient please visit this version.

View All Sections
  • Active ingredient

    Origanum Vulgare Leaf Extract 6.94%

  • Purpose

    Skin protectant

  • Use

    Helps moisturize skin by supplying moisture to the skin.

  • Warnings

    • For external use only.
    • Do not use on open skin wound.
    • In case of contact with eyes, rinse eyes thoroughly with water
    • Store away from direct sunlight.
  • Warnings

    • Keep out of reach of children.
  • Warnings

    If irritation or rash occurs stop use and ask a doctor.

  • Directions

    Take an appropriate amount and apply gently as if massaging according to the skin texture, then tap it for absorption.

  • Other information

    Store between 15-30℃

  • Inactive ingredients

    Water, Butylene Glycol, 1,2-Hexanediol, Sodium Hyaluronate, Origanum Vulgare Leaf Oil(250ppm), Rosmarinus Officinalis (Rosemary) Leaf Oil, Hydro genated Lecithin, Caprylic/Capric Triglyceride, Ammonium Acryloyldimethyltaurate/VP Copoly mer, Acrylates/C10-30 Alkyl Acrylate Crosspoly mer, Polyvinyl Alcohol, Ethylhexylglycerin

  • Package Label

    120g NDC: 90028-201-01 Label

  • INGREDIENTS AND APPEARANCE
    OREGANO ESSENCE 
    origanum vulgare leaf extract liquid
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:90028-201
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    OREGANO (UNII: 0E5AT8T16U) (OREGANO - UNII:0E5AT8T16U) OREGANO6.94 g  in 100 g
    Inactive Ingredients
    Ingredient NameStrength
    ETHYLHEXYLGLYCERIN (UNII: 147D247K3P)  
    WATER (UNII: 059QF0KO0R)  
    CARBOMER INTERPOLYMER TYPE A (55000 CPS) (UNII: 59TL3WG5CO)  
    1,2-HEXANEDIOL (UNII: TR046Y3K1G)  
    MEDIUM-CHAIN TRIGLYCERIDES (UNII: C9H2L21V7U)  
    AMMONIUM ACRYLOYLDIMETHYLTAURATE/VP COPOLYMER (UNII: W59H9296ZG)  
    POLYVINYL ALCOHOL, UNSPECIFIED (UNII: 532B59J990)  
    OREGANO LEAF OIL (UNII: 7D0CGR40U1)  
    HYALURONATE SODIUM (UNII: YSE9PPT4TH)  
    BUTYLENE GLYCOL (UNII: 3XUS85K0RA)  
    ROSEMARY OIL (UNII: 8LGU7VM393)  
    HYDROGENATED SOYBEAN LECITHIN (UNII: H1109Z9J4N)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:90028-201-01120 g in 1 BOTTLE; Type 0: Not a Combination Product09/03/2020
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    unapproved drug other09/03/2020
    Labeler - JMB COSLINE CO.,LTD (694837486)
    Registrant - JMB COSLINE CO.,LTD (694837486)
    Establishment
    NameAddressID/FEIBusiness Operations
    JMB COSLINE CO.,LTD694837486manufacture(90028-201)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!